0324 EMB 3a ET Step series B
BioCentury & Getty Images

Finance

With cancer foot forward, Step making strides toward clinic with €35M series B

French biotech considering accelerated pathway for lead program

French biotech considering accelerated pathway for lead program.

Mar 24, 2021 | 10:34 AM GMT

As Step contemplated two paths forward into autoimmune and cancer indications for its lead program, the French

Read the full 586 word article

How to gain access

Continue reading with a
two-week free trial.